retifanlimab,pembrolizumab,Bria-IMT
Incyte,Merck,BriaCell Therapeutics
[]
dr. william v. williams, briacell s president &amp; ceo, comments on the company's positive data presented at the 2023 . find details here: #aacr2023 $bctx $bctxw 
An immuno-oncology company developing targeted and effective immunotherapies for advanced breast cancer and other cancers. (Nasdaq: $BCTX, $BCTXW) (TSX: BCT)